Method for determining presence of cancer in a sample by assaying for expression of ECSA/DPPA-2 nucleotide sequences

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8354243
APP PUB NO 20100210522A1
SERIAL NO

12310802

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to the discovery of known molecule “DPPA-2” and a so-called “cancer-testis antigen.” DPPA-2 is also a possible cancer stem cell marker. One can determine presence of cancer by assaying for the molecule, and also prevent or treat cancer via administration of the molecule.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UCL BUSINESS PLC97 TOTTENHAM COURT ROAD THE NETWORK BUILDING LONDON W1T 4TP

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Caballero, Otavia L New York, US 4 12
Cebon, Jonathan Heidelberg, AU 13 126
John, Thomas Heidelberg, AU 91 4662
Monk, Marilyn London, GB 1 0
Svobodova, Suzanne Heidelberg, AU 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation